Ovarian cancer differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
! colspan="2" rowspan="4" |Diseases | ! colspan="2" rowspan="4" |Diseases | ||
| colspan=" | | colspan="6" |'''Clinical manifestations''' | ||
! colspan="4" rowspan="2" |Para-clinical findings | ! colspan="4" rowspan="2" |Para-clinical findings | ||
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | | colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | ||
Line 17: | Line 17: | ||
| rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Age of onset''' | | rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Age of onset''' | ||
| colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms''' | | colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms''' | ||
! colspan=" | ! colspan="2" rowspan="2" |Physical examination | ||
|- | |- | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
Line 26: | Line 26: | ||
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |vaginal bleeding/discharge | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |vaginal bleeding/discharge | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |GI dysturbance | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |GI dysturbance | ||
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Fever''' | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Fever''' | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Tenderness | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Tenderness | ||
Line 32: | Line 31: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | ||
|- | |- | ||
! colspan=" | ! colspan="14" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |Gynecologic | ||
|- | |- | ||
| rowspan="14" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Ovary|Ovarian]] | | rowspan="14" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Ovary|Ovarian]] | ||
Line 39: | Line 38: | ||
* Women in reproductive age (15 -45 y/o) | * Women in reproductive age (15 -45 y/o) | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px;" |– | ||
Line 60: | Line 58: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Women in reproductive age (15 -45 y/o) | * Women in reproductive age (15 -45 y/o) | ||
| style="background: #F5F5F5; padding: 5px;" |+/– | | style="background: #F5F5F5; padding: 5px;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | |||
| style="background: #F5F5F5; padding: 5px;" |+/– | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Depends on the underlying etiology | * Depends on the underlying etiology | ||
Line 82: | Line 79: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* >55 y/o | * >55 y/o | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 100: | Line 96: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* >55 y/o | * >55 y/o | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 120: | Line 115: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
Line 146: | Line 140: | ||
* 10-30 y/o | * 10-30 y/o | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
Line 174: | Line 167: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
Line 197: | Line 189: | ||
* Male infants | * Male infants | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
Line 226: | Line 217: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
Line 244: | Line 234: | ||
* It may cause Meigs syndrome (ovarian fibroma, ascites, and hydrothorax) | * It may cause Meigs syndrome (ovarian fibroma, ascites, and hydrothorax) | ||
* It may cause ovarian torsion | * It may cause ovarian torsion | ||
* It may cause pleural effusion | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Thecoma]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Thecoma]] | ||
Line 251: | Line 242: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Postmenopausal bleeding | * Postmenopausal bleeding | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
Line 280: | Line 270: | ||
* Postmenopausal bleeding | * Postmenopausal bleeding | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
Line 301: | Line 290: | ||
* 15 to 35 y/o | * 15 to 35 y/o | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
Line 328: | Line 316: | ||
* >55 y/o | * >55 y/o | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
Line 353: | Line 340: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
Based on underlying malignancy | Based on underlying malignancy | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
Line 373: | Line 357: | ||
* Imaging/biopsy | * Imaging/biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* The most common primary tumor is in colon, stomach, breast, lung, and contralateral ovary | * The most common primary tumor is in colon, stomach, breast, lung, and contralateral ovary | ||
* Based on underlying malignancy it may cause peural effusion | |||
|- | |- | ||
| rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Fallopian tube|Tubal]] | | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Fallopian tube|Tubal]] | ||
Line 381: | Line 366: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
Line 407: | Line 391: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
Line 428: | Line 411: | ||
* NA | * NA | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
Line 453: | Line 435: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | – | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
Line 473: | Line 454: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* >60 y/o | * >60 y/o | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
Line 499: | Line 479: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* We may see Latzko triad (abdominal pain, vaginal discgarge, pelvic mass) | * We may see Latzko triad (abdominal pain, vaginal discgarge, pelvic mass) | ||
* It may cause pleural effusion | |||
|- | |- | ||
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Uterus|Uterine]] | | rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Uterus|Uterine]] | ||
Line 506: | Line 487: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | – | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | – | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
Line 530: | Line 510: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
Line 559: | Line 538: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
Line 583: | Line 561: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
Line 602: | Line 579: | ||
* We do not perform [[CT scan]] and [[MRI]] in [[pregnancy]] but We may unintentionally image the [[pregnancy]] with [[CT scan]] and [[MRI]]. | * We do not perform [[CT scan]] and [[MRI]] in [[pregnancy]] but We may unintentionally image the [[pregnancy]] with [[CT scan]] and [[MRI]]. | ||
|- | |- | ||
! colspan=" | ! colspan="14" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |Non-gynecologic | ||
|- | |- | ||
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Gastrointestinal tract|GIT]] | | rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Gastrointestinal tract|GIT]] | ||
Line 610: | Line 587: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | – | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
Line 630: | Line 606: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* The most common [[complication]] of [[acute appendicitis]] | * The most common [[complication]] of [[acute appendicitis]] | ||
* It may cause pleural effusion | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Appendix cancer|Appendiceal neoplasm]]<ref name="WHO">Chapter 5: Tumours of the Appendix - IARC. https://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb2/bb2-chap5.pdf Accessed on January 15, 2019</ref> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Appendix cancer|Appendiceal neoplasm]]<ref name="WHO">Chapter 5: Tumours of the Appendix - IARC. https://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb2/bb2-chap5.pdf Accessed on January 15, 2019</ref> | ||
Line 637: | Line 614: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | – | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | – | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
Line 668: | Line 644: | ||
** [[HNPCC]] | ** [[HNPCC]] | ||
** [[Smoking]] | ** [[Smoking]] | ||
* It may cause pleural effusion | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Diverticular abscess]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Diverticular abscess]] | ||
Line 674: | Line 651: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
Line 692: | Line 668: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Diverticular abscess]] happens in almost 30-40% of patients with [[diverticulitis]] | * [[Diverticular abscess]] happens in almost 30-40% of patients with [[diverticulitis]] | ||
* It may cause pleural effusion | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Colorectal cancer]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Colorectal cancer]] | ||
Line 699: | Line 676: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | – | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | – | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
Line 729: | Line 704: | ||
In case of sever [[hydronephrosis]] or [[renal stone]] we may have [[pelvic]] [[pain]] | In case of sever [[hydronephrosis]] or [[renal stone]] we may have [[pelvic]] [[pain]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
Line 756: | Line 730: | ||
* ≥65 y/o | * ≥65 y/o | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
Line 787: | Line 760: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− |
Revision as of 14:24, 11 February 2019
Ovarian cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ovarian cancer differential diagnosis On the Web |
American Roentgen Ray Society Images of Ovarian cancer differential diagnosis |
Risk calculators and risk factors for Ovarian cancer differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Differentiating [Disease name] from other Diseases
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age of onset | Symptoms | Physical examination | |||||||||||
Lab Findings | Imaging | Immunohistopathology | |||||||||||
pelvic/abdominal pain or pressure | vaginal bleeding/discharge | GI dysturbance | Fever | Tenderness | CT scan/US | MRI | |||||||
Gynecologic | |||||||||||||
Ovarian | Follicular cysts |
|
+/– | – | – | – | +/– |
|
|
|
|
|
|
Theca lutein cysts |
|
+/– | – | – | – | +/– |
|
|
|
|
|
| |
Serous cystadenoma/carcinoma |
|
– |
|
| |||||||||
Mucinous cystadenoma/carcinoma |
|
– |
| ||||||||||
Endometrioma |
|
+ | + | +/– | – | + |
|
|
|
|
|
| |
Teratoma |
|
+/– | – | – | – | +/– |
|
|
|
|
|
| |
Dysgerminoma |
|
+ | +/– | – | – | +/– |
|
|
|
|
|
| |
Yolk sac tumor |
|
+ | – | – | – | + |
|
|
|
|
|
| |
Fibroma |
|
|
– | – | – | +/– |
|
|
|
|
|
| |
Thecoma |
|
+/– |
|
– | – | – |
|
|
|
|
|
| |
Granulosa cell tumor |
|
+ |
|
+/– | – | – |
|
|
|
|
|
| |
Sertoli-leydig cell tumor |
|
+/– | – | – | – | – |
|
|
|
|
|
| |
Brenner tumor |
|
+/– | – | – | – | – | – |
|
|
|
|
| |
Krukenberg tumor |
|
+/– | – | +/–
Based on underlying malignancy |
– | – |
|
|
|
|
|
| |
Tubal | tubo-ovarian abscess |
|
+ | + | – | + | + |
|
|
|
|
|
|
Ectopic pregnancy |
|
+ | + | +/– | – | + |
|
|
|
|
|
| |
Hydrosalpinx |
|
+ | – | – | – | +/– | – |
|
|
|
|
| |
Salpingitis |
|
+ | + | – | + | + |
|
|
|
|
|
| |
Fallopian tube carcinoma |
|
+ | + | + | – | +/– |
|
|
|
|
|
| |
Uterine | Leiomyoma |
|
+ | + | – | – | +/– |
|
|
|
|
|
|
Choriocarcinoma |
|
+ | + | +/– | – | + |
|
|
|
|
|
| |
Leiomyosarcoma |
|
+ | + | – | – | +/– |
|
|
|
| |||
Pregnancy |
|
+/− | +/− | +/− | – | – |
|
|
|
||||
Non-gynecologic | |||||||||||||
GIT | Appendiceal abscess |
|
+ | – | + | +/– | + |
|
|
|
| ||
Appendiceal neoplasm[1] |
|
+ | – | + | – | +/– |
|
|
|
|
| ||
Diverticular abscess |
|
+ | – | + | +/– | + |
|
|
|
| |||
Colorectal cancer |
|
+ | – | + | – | +/– |
|
|
|
|
| ||
Renal | Pelvic kidney |
|
−/+
In case of sever hydronephrosis or renal stone we may have pelvic pain |
– | − | − | − | − |
|
|
|
| |
Bladder cancer |
|
+ | – | – | – | – |
|
|
|
|
| ||
Others | Retroperitoneal sarcoma[2] |
|
+ | – | + | − | − |
|
|
|
|
|
check sites of cancer that may metastasize to the ovaries (eg, stomach, colorectal, breast)
check rectum, liver, spleen, lungs, inguinal or supraclavicular lymph nodes for ovary metastase
- Bladder tumour–associated antigen (BTA)
- Nuclear matrix proteins (NMP)
- Mucin and carcinoembryonic antigen (CEA)
References
- ↑ Chapter 5: Tumours of the Appendix - IARC. https://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb2/bb2-chap5.pdf Accessed on January 15, 2019
- ↑ Storm FK, Mahvi DM (July 1991). "Diagnosis and management of retroperitoneal soft-tissue sarcoma". Ann. Surg. 214 (1): 2–10. PMC 1358407. PMID 2064467.